People

Ralph Laufer

PhD, Chief Scientific Officer Ralph has an extensive experience in developing drugs in the central nervous system (CNS). He was previously CSO of Lysogene, a French biotech specialized in gene therapy targeting CNS diseases. Prior to this, he was Senior Vice President and Head of Discovery and Product Development at Teva Pharmaceutical Industries in Israel. Prior to Teva, he was the Scientific Director of IRBM, an Italian drug discovery CRO. Previously, Ralph was Head of Pharmacology at Merck Research Laboratories Rome. Ralph obtained his PhD in Biochemistry (summa cum laude) and M.Sc. in Chemistry from the Hebrew University of Jerusalem. He conducted postdoctoral training at the Institut Pasteur in Paris, and is the author of close to 100 scientific articles and an inventor on about 30 patents.